iShares Europe Developed Real Estate ETF (IFEU) Touches $37.81 Formed H&S; Iqvia Holdings (IQV) Shorts Decreased By 10.26%

Iqvia Holdings Inc (NYSE:IQV) had a decrease of 10.26% in short interest. IQV’s SI was 2.92 million shares in May as released by FINRA. Its down 10.26% from 3.26 million shares previously. With 1.30 million avg volume, 2 days are for Iqvia Holdings Inc (NYSE:IQV)’s short sellers to cover IQV’s short positions. The SI to Iqvia Holdings Inc’s float is 1.64%. The stock increased 0.54% or $0.72 during the last trading session, reaching $135.27. About 853,405 shares traded. IQVIA Holdings Inc. (NYSE:IQV) has risen 45.57% since May 16, 2018 and is uptrending. It has outperformed by 41.20% the S&P500. Some Historical IQV News: 24/04/2018 – IQVIA HOLDINGS INC IQV.N : CREDIT SUISSE NAMES CO TOP PICK IN NORTH AMERICAN HEALTHCARE TECHNOLOGY & DISTRIBUTION; 16/05/2018 – FDA-CALLED UPON IQVIA TO IMMEDIATELY RETAIN THIRD PARTY AUDITOR TO CONDUCT REVIEW OF DATA QUALITY, QUALITY CONTROL PROCEDURES OF CONTROLLED SUBSTANCE DATA UTILIZED BY FDA; 17/05/2018 – IQVIA REAFFIRMS ITS SECOND-QUARTER AND FULL-YEAR 2018 GUIDANCE, INCLUDING ADJUSTED EPS GROWTH OF 13.6% TO 20.4% AND 14.3% TO 19.9%, RESPECTIVELY; 17/05/2018 – IQVIA HOLDINGS INC IQV.N SEES FY 2018 REVENUE $10.05 BLN; 15/03/2018 – IQVIA Establishes Alliance with MuleSoft to Deliver Innovative Integration Technology to Life Sciences Companies; 16/05/2018 – FDA-WANTS TO ASSESS WHETHER ERRORS WERE MORE SYSTEMATIC AND WIDESPREAD, WANTS TO DETERMINE THE POTENTIAL IMPACT OF SUCH ERRORS ON FDA’S WORK; 02/05/2018 – IQVIA SEES 2Q ADJ EPS $1.17 TO $1.24, EST. $1.28; 17/05/2018 – IQVIA HOLDINGS INC IQV.N REAFFIRMS FY 2018 ADJUSTED SHR VIEW $5.20 TO $5.45; 16/05/2018 – IQVIA Holdings: Recently Made Correction to Kilogram Conversion Measurement; 12/03/2018 MDA Collaborates with IQVIA to Expand Disease Registry into the New MOVR Data Hub

iShares Europe Developed Real Estate ETF (IFEU) formed inverse H&S with $40.08 target or 6.00% above today’s $37.81 share price. iShares Europe Developed Real Estate ETF (IFEU) has $30.07M valuation. The ETF decreased 0.24% or $0.09 during the last trading session, reaching $37.81. About 176 shares traded. iShares Europe Developed Real Estate ETF (NASDAQ:IFEU) has declined 6.91% since May 16, 2018 and is downtrending. It has underperformed by 11.28% the S&P500.

More notable recent IQVIA Holdings Inc. (NYSE:IQV) news were published by: Benzinga.com which released: “Earnings Scheduled For May 1, 2019 – Benzinga” on May 01, 2019, also Finance.Yahoo.com with their article: “IQVIA Holdings, Inc. to Host Earnings Call – Yahoo Finance” published on May 01, 2019, Finance.Yahoo.com published: “United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives – Yahoo Finance” on May 07, 2019. More interesting news about IQVIA Holdings Inc. (NYSE:IQV) were released by: Businesswire.com and their article: “IQVIA’s OCE Technology Platform Selected by Salehiya Medical to Enhance Customer Experience in Saudi Arabia – Business Wire” published on April 25, 2019 as well as Businesswire.com‘s news article titled: “IQVIA Reports First-Quarter 2019 Results, Reaffirms Full-Year Guidance – Business Wire” with publication date: May 01, 2019.

Among 3 analysts covering IQVIA Holdings (NYSE:IQV), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. IQVIA Holdings had 4 analyst reports since February 19, 2019 according to SRatingsIntel. As per Tuesday, February 19, the company rating was maintained by Wells Fargo. The firm has “Overweight” rating given on Monday, March 18 by Barclays Capital. The rating was maintained by Argus Research with “Buy” on Monday, February 25.

Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. The company has market cap of $26.68 billion. It operates through three divisions: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. It has a 111.79 P/E ratio. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.

IQVIA Holdings Inc. (NYSE:IQV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.